DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 08.11.2017 / 10:36 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs Berlin (Germany) and Germantown, MD (U.S.A.), November 8, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced today that […]
Category: Press Releases
08. November 2017
Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs
Read more
05. November 2017
Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and Chief Scientific Officer
DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 05.11.2017 / 23:11 The issuer is solely responsible for the content of this announcement. Press release Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and Chief Scientific Officer – Dr. Jorge Garces is a proven senior executive with deep technology and development expertise […]
06. October 2017
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH)
Original-Research: Epigenomics AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Epigenomics AG Unternehmen: Epigenomics AG ISIN: DE000A11QW50 Anlass der Studie: Update Empfehlung: BUY seit: 06.10.2017 Kursziel: €7,30 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: 06.10.2017; vormals Add Analyst: Simon Scholes, CFA First Berlin Equity Research has […]
06. October 2017
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH)
Original-Research: Epigenomics AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Epigenomics AG Unternehmen: Epigenomics AG ISIN: DE000A11QW50 Anlass der Studie: Update Empfehlung: BUY seit: 06.10.2017 Kursziel: €7,30 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: 06.10.2017; vormals Add Analyst: Simon Scholes, CFA First Berlin Equity Research has […]
08. September 2017
Epigenomics AG issues convertible bonds
DGAP-News: Epigenomics AG / Key word(s): Corporate Action 08.09.2017 / 08:55 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG issues convertible bonds Berlin (Germany) and Germantown, MD (U.S.A.), September 8, 2017 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced that it has issued convertible […]
30. August 2017
Epigenomics Commences Post Approval Study on Epi proColon(R)
DGAP-News: Epigenomics AG / Key word(s): Study 30.08.2017 / 11:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics Commences Post Approval Study on Epi proColon(R) Berlin (Germany) and Germantown, MD (U.S.A.), August 30, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), today announced the initiation of a […]